PRME · Prime Medicine, Inc. · Fails to Deliver
$3.96
+0.13 (+3.39%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$694.67M
Shares
181.38M
Volume · Oct 20
3.64M
Avg daily vol (3M)
3.48M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 282 | $3.09 | $871 |
| 2026-09-25 | 1,420 | $3.07 | $4,359 |
| 2026-09-23 | 14,165 | $3.54 | $50,144 |
| 2026-09-22 | 56,416 | $3.19 | $179,967 |
| 2026-09-21 | 153,560 | $3.12 | $479,107 |
| 2026-09-14 | 18,713 | $3.13 | $58,572 |
| 2026-09-11 | 48,022 | $3.35 | $160,874 |
| 2026-09-10 | 68,740 | $3.47 | $238,528 |
| 2026-09-09 | 2,082 | $3.56 | $7,412 |
| 2026-09-08 | 449 | $3.70 | $1,661 |
| 2026-09-04 | 2,061 | $3.71 | $7,646 |
| 2026-09-03 | 15,901 | $3.67 | $58,357 |
| 2026-09-01 | 2,468 | $3.59 | $8,860 |
| 2026-08-31 | 413 | $3.61 | $1,491 |
| 2026-08-28 | 43,954 | $3.64 | $159,993 |
| 2026-08-27 | 10,587 | $3.58 | $37,901 |
| 2026-08-26 | 3,960 | $3.71 | $14,692 |
| 2026-08-25 | 839 | $3.25 | $2,727 |
| 2026-08-24 | 839 | $3.39 | $2,844 |
| 2026-08-20 | 15 | $3.54 | $53 |
| 2026-08-17 | 12,464 | $3.09 | $38,514 |
| 2026-08-14 | 68,330 | $3.17 | $216,606 |
| 2026-08-13 | 583 | $3.20 | $1,866 |
| 2026-08-07 | 290 | $2.95 | $856 |
| 2026-08-06 | 20,539 | $3.08 | $63,260 |
| 2026-08-03 | 15,134 | $2.92 | $44,191 |
| 2026-07-30 | 1,303 | $3.03 | $3,948 |
| 2026-07-28 | 50 | $3.01 | $151 |
| 2026-07-23 | 20,966 | $3.09 | $64,785 |
| 2026-07-20 | 6,321 | $3.13 | $19,785 |
Showing 1–30 of 30 settlements
Key facts
CIK
1894562
CUSIP
74168J101
13F (30d)
12 filings
12 filers
Visit website
Investor relations